Sleep Medicine Reviews
Volume 8, Issue 3 , Pages 199-212 , June 2004

Impaired sleep and rhythms in persons with cancer

  • Kathryn Lee

      Affiliations

    • University of California, San Francisco (UCSF) Box 0606, USA
    • Corresponding Author InformationCorresponding author. Tel.: +415-476-4442; fax: +415-753-2161
    • ,
  • Maria Cho

      Affiliations

    • University of California, San Francisco (UCSF) Box 0610, USA
    • Tel.: +415-476-4320; fax: +415-476-8899.
    • ,
  • Christine Miaskowski

      Affiliations

    • University of California, San Francisco (UCSF) Box 0610, USA
    • Tel.: +415-476-9407; fax: +415-476-8899.
    • ,
  • Marylin Dodd

      Affiliations

    • University of California, San Francisco (UCSF) Box 0610, USA
    • Tel.: +415-476-4320; fax: +415-476-8899.

References 

  1. American Cancer Society, www.cancer.org.
  2. Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care. 2001;10:245–255
  3. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med. 2002;54:1309–1321
  4. Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Onc. 2001;19:895–908
  5. National Sleep Foundation, www.sleepfoundation.org.
  6. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage. 1994;9:372–382
  7. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24:583–590
  8. Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract. 2000;14:275–290
  9. Brandberg Y, Mansson-Brahme E, Ringborg U, Sjoden PO. Psychological reactions in patients with malignant melanoma. Eur J Cancer. 1995;2:157–162
  10. Knobf MT. Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer. J Clin Oncol. 1986;4:678–684
  11. Omne-Ponten M, Holmberg L, Burns T, Adami HO, Bergstrom R. Determinants of the psycho-social outcome after operation for breast cancer. Results of a prospective comparative interview study following mastectomy and breast conservation. Eur J Cancer. 1992;28A:1062–1067
  12. Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum. 1998;25:915–920
  13. Greenberg DB, Sawicka J, Eisenthal S, Ross D. Fatigue syndrome due to localized radiation. J Pain Symptom Manage. 1992;7:38–45
  14. Berger AM, Farr L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. ONF. 1999;26:1663–1671
  15. Andrykowski MA, Curran SL, Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med. 1998;21:1–18
  16. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence H. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage. 2002;24:471–480
  17. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18:743–753
  18. Carpenter JS, Andrykowski MA. Menopausal symptoms in breast cancer survivors. ONF. 1999;26:1311–1317
  19. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16:1689–1696
  20. Stein KD, Jacobsen PB, Hann DM, et al.  Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom Manage. 2000;19:436–445
  21. Berger AM, Higgenbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. ONF. 2000;27:1443–1448
  22. Love RR, Cameron L, Connell BL, Leventhal H. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med. 1991;151:1842–1847
  23. Senie RT, Rosen PP, Rhodes P, Lesser ML. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med. 1991;115:337–342
  24. Badwe RA, Gregor WM, Chaudary MA, Richards MA, et al.  Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet. 1991;337:1261–1264
  25. Christman NJ, Oakley MG, Cronin SN. Developing and using preparatory information for women undergoing radiation therapy for cervical or uterine cancer. ONF. 2001;28:93–98
  26. Nail LM. Coping with intracavitary radiation treatment for gynecologic cancer. Cancer Pract. 1993;1:218–224
  27. Savard J, Miller SM, Mills M, O'Leary A, Harding H, et al.  Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer. Psychosom Med. 1999;61:496–507
  28. Irwin M, Smith TL, Gillin JC. Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosom Med. 1992;54:10–21
  29. Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage. 1993;8:196–200
  30. Krueger JM, Karnovsky ML. Sleep as a neuroimmune phenomenon: a brief historical perspective. Adv Neuroimmunol. 1995;5:5–12
  31. Lee KA, Miaskowski C, West C, Dodd M, Elder M, Paul S, et al. Changes in sleep and fatigue during radiation for prostate cancer. Sleep. 2003;26(1):
  32. Ginsburg ML, Quirt C, Ginsburg AD, MacKillop WJ. Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer. CMAJ. 1995;152:701–708
  33. Sarna L. Correlates of symptom distress in women with lung cancer. Cancer Pract. 1993;1:21–28
  34. Silberfarb PM, Hauri PJ, Oxman TE, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol. 1993;11:997–1004
  35. Portenoy RK, Thaler HT, Kornblith AB, et al.  Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3:183–189
  36. Nordin K, Glimelius B. Predicting delayed anxiety and depression in patients with gastrointestinal cancer. Br J Cancer. 1999;79:525–529
  37. Faithfull S. Patients' experiences following cranial radiotherapy: a study of the somnolence syndrome. J Adv Nurs. 1991;16:939–946
  38. Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A, et al.  Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head and Neck. 1997;19:169–175
  39. Munro AJ, Potter S. A quantitative approach to the distress caused by symptoms in patients treated with radical radiotherapy. Br J Cancer. 1996;74:640–647
  40. Molassiotis A. A correlational evaluation of tiredness and lack of energy in survivors of haematological malignancies. Eur J Cancer Care. 1999;8:19–25
  41. Wang XH, Giralt SA, Mendoza TR, Engstrom MC, et al.  Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol. 2002;20:1319–1328
  42. Smets EMA, Visser MRM, Willems-Groot AFMN, Garssen B, et al.  Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer. 1998;78:899–906
  43. Smets EMA, Visser MRM, Willems-Groot AFMN, et al.  Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. Br J Cancer. 1998;78:907–912
  44. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59:131–136
  45. Lawrence CC, Gilbert CJ, Peters WP. Evaluation of symptom distress in a bone marrow transplant outpatient environment. Ann Pharmacother. 1996;30:941–945
  46. Andrykowski MA, Carpenter JS, Greiner CB, et al.  Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant. 1997;20:669–679
  47. Longman AJ, Braden CJ, Mishell MH. Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time. ONF. 1999;26:909–915
  48. Krech RL, Walsh D. Symptoms of pancreatic Cancer. J Pain Symptom Manage. 1991;6:360–367
  49. Okuyama T, Tanaka K, Akechi T, Kugaya A, et al.  Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. J Pain Symptom Manage. 2001;22:554–564
  50. Geels P, Eisenhauer E, Bezjak A, Zee B, Day A. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastic breast cancer. J Clin Oncol. 2000;12:2396–2405
  51. Miaskowski C, Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage. 1999;17:320–332
  52. Lewin DS, Dahl RE. Importance of sleep in the management of pediatric pain. J Dev Behav Pediatr. 1999;20:244–252
  53. Hockenberry-Eaton M, Hinds PS, Alcoser P, O'Neill JB, et al.  Fatigue in children and adolescents with cancer. J Ped Oncol Nurs. 1998;15:172–182
  54. Wilcox S, King A. Sleep complaints in older women who are family caregivers. J Gerontol: Psychol Sci. 1999;54B:P189–P198
  55. Picot SJF, Zauszniewski JA, Debanne SM, Holston EC. Mood and blood pressure responses in black female caregivers and noncaregivers. Nurs Res. 1999;48:150–161
  56. Carter PA, Chang BL. Sleep and depression in cancer caregivers. Cancer Nurs. 2000;23:410–415
  57. Given BA, Given CW, Kozachik S. Family support in advanced cancer. CAA Cancer J Clin. 2001;51:213–231
  58. Ferrell BR, Rhiner M, Shapiro B, Dierkes M. The experience of pediatric cancer pain. Part I: impact of pain on the family. J Ped Nurs. 1994;9:368–379
  59. Scheving LE, Burns ER, Pauly JE, Halberg F, Haus E. Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-B-D-arabinofuranosylcytosine. Cancer Res. 1977;37:3648–3655
  60. Hrushesky WJ. Circadian timing of cancer chemotherapy. Science. 1985;5:73–75
  61. Levi F, Misset J, Brienza S, Adam R, Metzger G, et al.  A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. Cancer. 1992;69:893–900
  62. Levi FA, Zidani R, Vannetzel J, Perpoint B, Focan C, et al.  Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst. 1994;86:1608–1617
  63. Levi F, Zidani R, Misset J. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet. 1997;350:681–686
  64. Sato S, Irie T, Kanamori Y, Akeshima R. Timing of G-CSF administration based on the circadian rhythm in patients with ovarian cancer. Am J Clin Oncol. 2002;25:289–290
  65. Metzger G, Massari C, Etienne M-C, Comisso M, et al.  Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: relationship with mucosal toxicity in patients with cancer. Clin Pharmacol Ther. 1994;56:190–201
  66. Mormont MC, Levi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70:241–247
  67. Mormont MC, De Prins J, Levi F. Assessment of activity rhythms of wrist actigraphy: preliminary results in 30 patients with colorectal cancer. Pathol Biol. 1996;44:165–171
  68. Mormont MC, Waterhouse J. Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Int. 2002;19:313–323
  69. Mormont MC, Waterhouse JM, Bleuzen P, Giacchetti S, et al.  Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 2000;6:3038–3045
  70. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000
  71. Stiefel FC, Kornblith AB, Holland JC. Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer. 1990;65:1048–1053
  72. Derogatis LR, Feldstein M, Morrow G, Schmale A, et al.  A survey of psychotropic drug prescriptions in an oncology population. Cancer. 1979;44:1919–1929
  73. Engstrom CA, Strohl RA, Rose L, et al.  Sleep alterations in cancer patients. Cancer Nurs. 1999;22:143–148
  74. Love RR, Leventhal H, Easterline DV, Nerenz DR. Side effects and emotional distress during cancer chemotherapy. Cancer. 1989;63:604–612
  75. Vogelzang NJ, Breitbart W, Cella D, Curt GA, et al.  Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment study. Semin Hematol. 1997;34(2):4–12
  76. Cover H, Irwin M. Immunity and depression: insomnia, retardation, and reduction of natural killer cell activity. J Behav Med. 1994;17:217–223
  77. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, et al.  Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 1999;84:2603–2607
  78. Alapin I, Fichten CS, Libman E, Creti L, et al.  How is good and poor sleep in older adults and college students related to daytime sleepiness, fatigue, and ability to concentrate?. J Psychosom Res. 2000;49:381–390
  79. Richardson A, Ream EK. Self-care behaviours initiated by chemotherapy patients in response to fatigue. Int J Nurs Stud. 1997;34:35–43
  80. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry. 1994;151:1172–1180
  81. Murtaugh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995;63:79–89
  82. Davidson JR, Waisberg JL, Brundage MD, MacLean AW. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psycho-Oncology. 2001;10:389–397
  83. Cannici J, Malcolm R, Peek LA. Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry. 1983;14:251–256
  84. Lee KA. Sleep and fatigue. Annu Rev Nurs Res. 2000;19:249–273
  85. Segar ML, Katch VL, Roth RS, Garcia AW, et al.  The effect of aerobic exercise on self-esteem and depressive and anxiety symptoms among breast cancer survivors. Oncol Nurs Forum. 1998;25:107–113
  86. Mock V, Hassey Dow K, Meares CJ, et al.  Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. ONF. 1997;24:991–1000
  87. Dimeo F, Bertz H, Finke J. An aerobic exercise programme for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant. 1996;18:1157–1160
  88. Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer. 1999;85:2273–2277
  89. Spielman AJ, Glovinsky PB. The varied nature of insomnia. In P Hauri (Ed). Case studies in insomnia. New York: Plenum Press, 1991, pp.1–15.

PII: S1087-0792(03)00073-X

doi: 10.1016/j.smrv.2003.10.001

Sleep Medicine Reviews
Volume 8, Issue 3 , Pages 199-212 , June 2004

Article Tools